Katie Miller, PhD
About Katie Miller, PhD
Katie Miller, PhD, is a Scientist II specializing in Peptide/Oligonucleotide at Entrada Therapeutics in Boston, Massachusetts. With a background in organic chemistry and experience in various research roles, she is dedicated to science communication and outreach.
Work at Entrada Therapeutics
Katie Miller currently holds the position of Scientist II - Peptide/Oligonucleotide at Entrada Therapeutics in Boston, Massachusetts. She has been with the company since 2023, focusing on the development and research of peptide and oligonucleotide therapies. Her role involves applying her expertise in organic chemistry and analytical development to advance therapeutic solutions.
Previous Experience in Pharmaceutical Research
Before joining Entrada Therapeutics, Katie Miller worked at several notable organizations. She served as a Scientist II-Chemistry at Resolute Bio for nine months in 2022. Following that, she was an Analytical Research Scientist at Vertex Pharmaceuticals from 2021 to 2022. Additionally, she worked as a Scientist Bioconjugation at Mersana Therapeutics from 2022 to 2023. These roles contributed to her diverse skill set in small molecule analytical development and antibody-drug conjugation.
Education and Expertise
Katie Miller completed her Bachelor of Science in Biochemistry at The University of Alabama from 2012 to 2016. She then pursued her Doctor of Philosophy in Chemistry at Rice University, where she was a Graduate Student Researcher from 2016 to 2021. Her academic background and training as an organic chemist provide a strong foundation for her current work in peptide and oligonucleotide research.
Passion for Science Communication
Katie Miller is passionate about science communication and outreach. She actively engages in efforts to promote understanding and interest in scientific research. Her commitment to effective communication helps bridge the gap between complex scientific concepts and public understanding.